Inherited salt-losing tubulopathy: an old condition but a new category of tubulopathy.
Bartter syndrome (BS) and Gitelman syndrome (GS) are syndromes associated with congenital tubular dysfunction characterized by hypokalemia and metabolic alkalosis. Clinically, BS is classified into two types: the severe antenatal/neonatal type, which develops during the fetal period with polyhydramnios and preterm delivery; and the relatively mild classical type, which is usually found during infancy with failure to thrive. GS can be clinically differentiated from BS due to its age of onset, usually after school age, or laboratory findings of hypomagnesemia and hypocalciuria. Recent advances in molecular biology have shown that these diseases can be genetically classified into type 1 to 5 BS and GS. As a result, it has become clear that the clinical classification of antenatal/neonatal BS, classical BS, and GS does not always correspond to the clinical symptoms associated with the genotypes in a one-to-one manner, especially there is clinically no clear border between type 3 BS and GS. This has caused confusion for clinicians in the clinical diagnosis of these diseases. It has been proposed that the disease name "inherited salt-losing tubulopathy" can be used for cases of tubulopathies accompanied by hypokalemia and metabolic alkalosis. It is reasonable to use this disease name prior to a genetic typing into type 1-5 BS or GS. This can avoid confusion in a clinical setting. In this article, we review causative genes and phenotypic correlations, diagnosis, and treatment strategies for salt-losing tubulopathy as well as the clinical characteristics of pseudo-BS/GS which disease status can also be called "salt-losing disorder".